Page results
-
A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
Update about our hospital on Gray's Inn Road
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
File results
-
-
-
-
-
FOI201785 Opthalmology treatments
-
FOI201795 Patient administration system
-
FOI201791 IVF treatment
-
FOI201788 Patient discharge
-
FOI201786 EU national staff leaving posts
-
FOI/2023/0326 - Risk management system reporting rates for adverse events